Cloning, Expression, and Characterization of Mouse Tissue Factor Pathway Inhibitor (TFPI)

Tissue factor pathway inhibitor (TFPI) acts to regulate the initiation of coagulation by first inhibiting factor Xa. The complex of factor Xa/TFPI then inhibits the factor VIIa/tissue factor complex. The cDNA sequences of TFPI from several different species have been previously reported. A high level of similarity is present among TFPIs at the molecular level (DNA and protein sequences) as well as in biochemical function (inhibition of factor Xa, VIIa/tissue factor). In this report, we used a PCR-based screening method to clone cDNA for full length TFPI from a mouse macrophage cDNA library. Both cDNA and predicted protein sequences show significant homology to the other reported TFPI sequences, especially to that of rat. Mouse TFPI has a signal peptide of 28 amino acid residues followed by the mature protein (in which the signal peptide is removed) which has 278 amino acid residues. Mouse TFPI, like that of other species, consists of three tandem Kunitz type domains. Recombinant mouse TFPI was expressed in the human kidney cell line 293 and purified for functional assays. When using human clotting factors to investigate the inhibition spectrum of mouse TFPI, it was shown that, in addition to human factor Xa, mouse TFPI inhibits human factors VIIa, IXa, as well as factor XIa. Cloning and expression of the mouse TFPI gene will offer useful information and material for coagulation studies performed in a mouse model system.

[1]  D. Stafford,et al.  The roles of factor VII's structural domains in tissue factor binding. , 1995, Biochemistry.

[2]  T. Miyata,et al.  Effect of heparin on the inhibition of factor Xa by tissue factor pathway inhibitor: a segment, Gly212-Phe243, of the third Kunitz domain is a heparin-binding site. , 1995, Biochemistry.

[3]  G. Broze,et al.  Complementary DNA sequencing of canine tissue factor pathway inhibitor reveals a unique nanomeric repetitive sequence between the second and third Kunitz domains. , 1994, Biochemical Journal.

[4]  W. Kisiel,et al.  Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[5]  T. Abumiya,et al.  Amino acid sequence and inhibitory activity of rhesus monkey tissue factor pathway inhibitor (TFPI): comparison with human TFPI. , 1994, Journal of biochemistry.

[6]  M. King,et al.  A rapid and efficient, nonradioactive method for screening recombinant DNA libraries. , 1994, BioTechniques.

[7]  R. Wesselschmidt,et al.  Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin. , 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[8]  M. Emi,et al.  cDNA cloning and expression of rat tissue factor pathway inhibitor (TFPI). , 1992, Journal of biochemistry.

[9]  R. Wesselschmidt,et al.  Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa. , 1992, Blood.

[10]  G. Broze,et al.  The lipoprotein-associated coagulation inhibitor. , 1991, Progress in hemostasis and thrombosis.

[11]  R. Wesselschmidt,et al.  cDNA sequence of rabbit lipoprotein-associated coagulation inhibitor. , 1990, Nucleic acids research.

[12]  K. Norris,et al.  Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions. , 1990, The Journal of biological chemistry.

[13]  D. Monroe,et al.  Characterization of the functional defect in factor IX Alabama. Evidence for a conformational change due to high affinity calcium binding in the first epidermal growth factor domain. , 1990, The Journal of biological chemistry.

[14]  Susan G. Brown,et al.  Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor , 1989, Nature.

[15]  J. Miletich,et al.  Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. , 1988, The Journal of biological chemistry.

[16]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[17]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Lundblad A rapid method for the purification of bovine thrombin and the inhibition of the purified enzyme wtih phenylmethylsulfonyl fluoride. , 1971, Biochemistry.